*Please cite this paper as:* Ghane Shahrbaf F, Assadi F. Drug-induced renal disorders. J Renal Inj Prev. 2015; 4(3): 57-60. DOI: 10.12861/jrip.2015.12

Implication for health policy/practice/research/medical education: {#imp1}
==================================================================

Drug-induced nephrotoxicity are more common among infants and young children and in certain clinical situations such as underlying renal dysfunction and cardiovascular disease. Drugs can cause acute renal injury, intra-renal obstruction, interstitial nephritis, nephrotic syndrome, and acid-base and fluid electrolytes disorders. Early detection of drugs adverse effects is important to prevent progression to end-stage renal disease. Preventive measures requires knowledge of mechanisms of drug-induced nephrotoxicity, understanding patients and drug-related risk factors coupled with therapeutic intervention by correcting risk factors, assessing baseline renal function before initiation of therapy, adjusting the drug dosage and avoiding use of nephrotoxic drug combinations.

Introduction {#s1}
============

Drug-induced nephrotoxicity is a common problem in clinical medicine and the incidence of drug-related acute kidney injury (AKI) may be as high as 60 percent ([@R1]-[@R4]). The condition can be costly and may require multiple interventions, including hospitalization ([@R5]). This article provides a summary of the most common mechanisms of drug-induced nephrotoxicity and prevention strategies.

Pathophysiologic mechanism of drug-induced nephrotoxicity is complex and often mediated through alteration of intraglomerular hemodynamics, impaired tubular secretion, inflammation, uric acid deposition, rhabdomyolysis, and thrombotic microangiopathy ([@R6]-[@R8]). Patients with underlying renal insufficiency, defined as glomerular filtration rate (GFR) less than 60 mL/minute/1.73 m^2^, heart failure, sepsis, and intravascular depletion are particularly vulnerable to developing nephrotoxicity ([Table 1](#T1){ref-type="table"}).

Aminoglycoside antibiotics, non-steroidal anti-inflammatory drugs (NSAIDs), contrast agents, and angiotensin converting enzyme inhibitors (ACEIs) are the most common cause of AKI in hospitalized patients ([@R2]). The risk of contrast-induced nephropathy is highest in diabetics and chronic kidney disease diabetes ([@R9]).

"Drugs can cause nephrotoxicity by altering intraglomeu- lar hemodynamics and decreasing GFR (ACEI, angiotensin-converting enzyme blockers \[ARBs\], NSAID, cyclo- sporine, and tacrolimus) ([@R10]-[@R15])."

"Certain drugs such as ampicillin, ciprofloxacin, sulfon- amides, acyclovir, ganciclovir, methotrexate and triam- terene are associated with crystal nephropathy ([@R16],[@R17]). Crystal nephropathy may also results from the use of che- motherapy due to uric acid and calcium phosphate crystal deposition ([@R16],[@R17])."

"Statins and alcohol may induce rhabdomyolysis because of a toxic effect on myocyte function, or ([@R18]-[@R20]). Drugs most often associated with thrombotic microangiopathy include antiplatelet agents (e.g., cyclosporine, mitomycin- C, and quinine ([@R21],[@R22])."

Drugs associated with tubular cell toxicity and acute in- terstitial nephropathy include aminoglycosides, ampho- tericin B, cisplatin, beta lactams, quinolones, rifampin, sulfonamides, vancomycin, acyclovir, and contrast agents ([@R4],[@R10],[@R11]). These agents induce renal tubular cell injury by impairing mitochondrial function and interfering with tubular transport and increasing oxidative stress and free radicals ([@R6],[@R10]). Chronic use of acetaminophen, aspirin, di- uretics and lithium is associated with chronic interstitial nephritis leading to fibrosis and renal scarring ([@R11],[@R20]-[@R23]).

Patient-related risk factors {#s2}
============================

Drug-induced renal disorders are more common in certain patients and in specific clinical situations. Infants and young children with extracellular volume depletion, sepsis, renal impairment, cardiovascular disease, diabetes, or prior exposure to radio contrast agents are at risk of developing drug nephrotoxicity.

Prevention strategies {#s3}
=====================

Preventive strategies should target the safety of prescribing drug, monitoring their potential nephrotoxicity, correcting risk factors for nephrotoxicity.

Before initiation the drug therapy, ensure adequate hydration and avoid the use of nephrotoxic drugs whenever possible ([@R23]-[@R25]). Correct intravascular depletion to maintain renal perfusion before initiation of nephrotoxic agents ([@R24],[@R26]). Administer drug orally and use the lowest effective dose and shortest duration of therapy whenever possible ([@R27],[@R28]). Maintain drug levels within the recommended therapeutic range. Use less toxic analgesics with the lowest prostaglandins activity such as acetaminophen in patients with chronic pain and limit the duration of therapy. Discontinue or reduce the dose of nephrotoxic drug with the first sign of toxicity. Monitor renal function and serum drug concentrations during drug therapy.

Use the lowest dose of low osmolar contrast agent in patients with pre-existing renal insufficiency, heart failure, and diabetes. Ensure adequate hydration with normal saline or sodium bicarbonate infusion. Consider acetazolamide and monitor GFR 24-48 hours post exposure ([@R26]).

###### The most commonly used nephrotoxic drugs

  ------------------------------------------------- ----------------------------------------- --------------------------------------------------------------------------------------
  **Medication**                                    **Drug category**                         **Renal toxicity**
  Acetaminophen                                     Non-narcotic analgesic                    Chronic interstitial nephritis, acute tubular necrosis
  Acetazolamide                                     Carbonic-anhydrase inhibitor              Proximal renal tubular acidosis
  Acyclovir                                         Antiviral                                 Acute interstitial nephritis, crystal nephropathy
  Allopurinol                                       Hypouricemic agent                        Acute interstitial nephritis
  Aspirin                                           Non-narcotic analgesic                    Chronic interstitial nephritis
  Amitriptyline                                     Antidepressant                            Rhabdomyolysis
  Aminoglycosides                                   Antimicrobial                             Acute tubular necrosis
  Amphotericin B                                    Antifungal                                Acute tubular necrosis, distal renal tubular acidosis
  Angiotensin-converting enzyme inhibitors (ACEI)   Antihypertensive                          Acute kidney injury
  Angiotensin receptor blockers (ARB)               Antihypertensive                          Acute kidney injury
  Benzodiazepines                                   Sedative-Hypotonic                        Rhabdomyolysis
  Beta lactams                                      Antimicrobial                             Acute interstitial nephritis
  Carbenicillin                                     Antimicrobial                             Metabolic alkalosis
  Cephalosporin                                     Antimicrobial                             Acute tubular necrosis
  Cholpropamide                                     Sulfonylureas                             Hyponatremia, syndrome inappropriate ADH secretion
  Cimetidine                                        Gastrointestinal                          Acute interstitial nephritis
  Cisplatin                                         Antineoplastic                            Chronic interstitial nephritis
  Clopidogrel                                       Antiplatelet                              Thrombotic miroangiopathy
  Cocaine                                           Narcotic analgesic                        Rhabdomyolysis
  Contrast agents                                   Contrast medium                           Acute tubular necrosis
  Cortisone                                         Corticosteroid                            Metabolic alkalosis, hypertension
  Cyclophosphamide                                  Antineoplastic                            Hemorrhagic cystitis
  Cyclosporine                                      Immunosuppressive                         Acute tubular necrosis, chronic interstitial nephritis, thrombotic microangiopathy
  D-penicillamine                                   Antirheumatic                             Nephrotic syndrome
  Diphenhydramine                                   Antihistamine                             Rhabdomyolysis
  Furosemide                                        Loop diuretic                             Acute interstitial nephritis
  Ganciclovir                                       Antiviral                                 Crystal nephropathy
  Gold Na thiomalate                                Aniarthritic                              Glomerulonephritis, nephrotic syndrome
  Haloperidol                                       Antipsychotic                             Rhabdomyolysis
  Indinavir                                         Antiviral                                 Acute interstitial nephritis, crystal nephropathy
  Interferon-alfa                                   Antineoplastic                            Glomerulonephritis
  Lansoprazole                                      Proton pump inhibitor                     Acute interstitial nephritis
  Lithium                                           Antipsychotic                             Chronic interstitial nephritis, glomerulonephritis, rhabdomyolysis
  Methadone                                         Narcotic analgesic                        Rhabdomyolysis
  Methamphetamine                                   Psychostimulant                           Rhabdomyolysis
  Methotrexate                                      Antineoplastic                            Crystal nephropathy
  Mitomycin-C                                       Antineoplastic                            Thrombotic microangiopathy
  Naproxen                                          Nonsteroidal anti-inflammatory            Acute and chronic interstitial nephritis, acute tubular necrosis, glomerulonephritis
  Omeprazole                                        Proton pump inhibitor                     Acute interstitial nephritis
  Pamidronate acid                                  Bisphosphonate, osteoporosis prevention   Glomerulonephritis
  Pantoprazole                                      Proton pump inhibitor                     Acute interstitial nephritis
  Penicillin G                                      penicillin                                Glomerulonephritis
  Pentamidine                                       Antimicrobial                             Acute tubular necrosis
  Phenformin                                        Hypoglycemic                              Lactic acidosis
  Phenacetin                                        Non-narcotic analgesic                    Chronic interstitial nephritis
  Phenytoin                                         Anticonvulsant                            Acute interstitial nephritis, diabetes insipidus
  Probenecid                                        Uricosuric                                Crystal nephropathy, nephrotic syndrome
  Puromycin                                         Antimicrobial                             Nephrotic syndrome
  Quinine                                           Muscle relaxant                           Thrombotic microangiopathic
  Quinolones                                        Antimicrobial                             Acute interstitial nephritis, crystal nephropathy
  Rifampin                                          Antimicrobial                             Acute interstitial nephritis
  Ranitidine                                        Gastrointestinal                          Acute interstitial nephritis
  Statins                                           Lipid- lowering                           Rhabdomyolysis
  Sulfonamides                                      Antimicrobial                             Acute interstitial nephritis, crystal nephropathy
  Tacrolimus                                        Immunosuppressive                         Acute tubular necrosis
  Tetracycline                                      Antimicrobial                             Acute tubular necrosis
  azides                                            Diuretic                                  Acute interstitial nephritis
  Tolbutamide                                       Hypoglycemic                              Nephrotic syndrome
  Vancomycine                                       Antimicrobial                             Acute interstitial nephritis
  ------------------------------------------------- ----------------------------------------- --------------------------------------------------------------------------------------

The information in this table has been obtained from numerous literature sources. For additional information on specific drugs, readers should consult the primary literature.

Estimate of renal function {#s4}
==========================

As a general rule, when a new drug is prescribed, baseline renal function should be evaluated before initiating the nephrotoxic medication. Close monitoring of renal function is also essential during the course of therapy. There are several ways to estimate GFR in children. One of the easiest and more practical one is Schwartz formula using the following formula ([@R27]):

GFR (ml/min/1.73 m^2^) = Length (cm) × k/serum creatinine (mg/dL)

k = 0.35 (infants 1-4 weeks)

k= 0.45 (4-52 weeks)

k = 0.55 (children 1-13 years)

k = 0.55 (girls 14-17 years)

k = 0.70 (boys 14-18 years)

Correct intravascular depletion to maintain renal perfusion before initiation of nephrotoxic agents ([@R24]). Use analgesics with less prostaglandin activity such as aspirin and acetaminophen. Monitor renal function and serum drug concentrations during drug therapy and use the lowest effective dose and the shortest duration of therapy whenever possible ([@R27],[@R28]).
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